PMID: 11898526Mar 20, 2002Paper

Spectrum and classification of inflammatory demyelinating diseases of the central nervous system

Current Neurology and Neuroscience Reports
B Kalman, F D Lublin

Abstract

The aim of this review is to highlight recent observations concerning the pathogenesis of acute and chronic inflammatory demyelinating diseases in the central nervous system. Without attempting to provide a didactic classification or a complete survey, we emphasize the discriminative nature of new clinical, imaging, and immunopathologic data, which, even in the absence of specific molecular markers, modify our views about the nosologic relations among these overlapping clinicopathologic entities. In the light of new findings, multiple sclerosis may represent a spectrum of demyelinating diseases rather than a single entity.

References

Apr 1, 1995·Seminars in Arthritis and Rheumatism·C A von Mühlen, E M Tan
Aug 1, 1993·Annals of Neurology·R N MandlerM Kornfeld
Apr 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·J I O'RiordanD H Miller
Dec 1, 1996·The Journal of Experimental Medicine·S D D'SouzaJ P Antel
Apr 29, 1998·Brain : a Journal of Neurology·L FuD L Arnold
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·K G BeckerJ M Trent
Sep 25, 1999·Journal of Neuroimmunology·F Lu, B Kalman
Sep 25, 1999·Neurology·D M WingerchukB G Weinshenker
Sep 28, 1999·Current Opinion in Neurology·B C KieseierH P Hartung
Dec 29, 1999·Nature Medicine·T SmithL Turski
Dec 29, 1999·Nature Medicine·D PittC S Raine
Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A HolzM B Oldstone
Jan 25, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·M RovarisM Filippi
Mar 1, 2000·Journal of Neuroimmunology·K A Sabelko-DownesA H Cross
Jun 14, 2000·Annals of Neurology·J J ArchelosH P Hartung
Jun 14, 2000·Annals of Neurology·A J ThompsonW I McDonald

❮ Previous
Next ❯

Citations

Jan 14, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·N PutzkiZ Katsarava
Nov 30, 2010·Journal of Neuroimmunology·Ron Milo, Hillel Panitch
Sep 16, 2008·Revue neurologique·B Brochet
Oct 16, 2004·Cephalalgia : an International Journal of Headache·D D'AmicoG Bussone
Feb 8, 2002·American Journal of Alzheimer's Disease and Other Dementias·Eduardo Adonias DeSousaBernadette Kalman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.